Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Bioorg Chem ; 150: 107536, 2024 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-38878751

RESUMO

Carboxylesterase 1 (CES1), a member of the serine hydrolase superfamily, is involved in a wide range of xenobiotic and endogenous substances metabolic reactions in mammals. The inhibition of CES1 could not only alter the metabolism and disposition of related drugs, but also be benefit for treatment of metabolic disorders, such as obesity and fatty liver disease. In the present study, we aim to develop potential inhibitors of CES1 and reveal the preferred inhibitor structure from a series of synthetic pyrazolones (compounds 1-27). By in vitro high-throughput screening method, we found compounds 25 and 27 had non-competitive inhibition on CES1-mediated N-alkylated d-luciferin methyl ester (NLMe) hydrolysis, while compound 26 competitively inhibited CES1-mediated NLMe hydrolysis. Additionally, Compounds 25, 26 and 27 can inhibit CES1-mediated fluorescent probe hydrolysis in live HepG2 cells with effect. Besides, compounds 25, 26 and 27 could effectively inhibit the accumulation of lipid droplets in mouse adipocytes cells. These data not only provided study basis for the design of newly CES1 inhibitors. The present study not only provided the basis for the development of lead compounds for novel CES1 inhibitors with better performance, but also offered a new direction for the explore of candidate compounds for the treatment of hyperlipidemia and related diseases.


Assuntos
Adipócitos , Hidrolases de Éster Carboxílico , Inibidores Enzimáticos , Pirazolonas , Humanos , Hidrolases de Éster Carboxílico/metabolismo , Hidrolases de Éster Carboxílico/antagonistas & inibidores , Adipócitos/efeitos dos fármacos , Adipócitos/metabolismo , Adipócitos/citologia , Animais , Camundongos , Pirazolonas/farmacologia , Pirazolonas/química , Pirazolonas/síntese química , Relação Estrutura-Atividade , Inibidores Enzimáticos/farmacologia , Inibidores Enzimáticos/química , Inibidores Enzimáticos/síntese química , Estrutura Molecular , Células Hep G2 , Diferenciação Celular/efeitos dos fármacos , Relação Dose-Resposta a Droga , Células 3T3-L1
2.
Dalton Trans ; 39(44): 10617-25, 2010 Nov 28.
Artigo em Inglês | MEDLINE | ID: mdl-20886135

RESUMO

A series of metal-organic complexes based on d(10) metals and the ligand H(4)bbh (H(4)bbh = benzene-1, 2, 4, 5-biformhydrazide), formed through hydrothermal in situ acylate reaction of H(4)bta (H(4)bta = benzene-1, 2, 4, 5-tetracarboxylic acid) with hydrazine hydrate (N(2)H(4)·H(2)O), have been prepared and structurally characterized by single-crystal X-ray diffraction. Compounds [Zn(µ(2)-H(2)bbh)(phen)(H(2)O)](2) (1) (phen = 1, 10-phenanthroline) and [Zn(µ(2)-H(2)bbh)(2, 2'-bpy)](2) (2) (2, 2'-bpy = 2, 2'-bipyridine) are both dinuclear complexes in which bridging ligands H(2)bbh(2-) display different µ(2)- coordination modes. [Zn(µ(2)-H(2)bbh)(1/2)(µ(2)-H(2)bbh)(1/2)(H(2)O)](n) (3) exhibits a two-dimensional (2-D) layer structure containing simultaneously two kinds of different coordination modes of H(2)bbh(2-): µ(2)-bidentate and µ(4)-tetradentate. [Cd(µ(3)-H(2)bbh)(phen)](n) (4) consists of one-dimensional (1-D) double-metal chains. The crystal structures of these compounds are stabilized by hydrogen bonds and π···π interactions, forming three-dimensional supramolecular networks. All of the compounds were characterized by IR, UV-vis spectra and elemental analysis and they show good fluorescence properties in the solid state at room temperature. In order to understand the emission mechanism, we carried out TDDFT calculations on the excited electronic states of compound 2.

3.
J Inorg Biochem ; 99(8): 1602-10, 2005 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-15951017

RESUMO

A group of four binuclear sulfur-bridged molybdenum-polycarboxylato complexes with homocitrate, citrate, cysteine, ethylenediaminetetraacetate ligands, respectively, have been synthesized and characterized. These complexes were prepared in order to study the interaction of Mo and homocitrate in the FeMo-co of nitrogenases. In the structures of K4(NH4)2[Mo2O2S2(C6H4O7)2].10H2O (2), (NH4)2[Mo2O2S2(C3H5SNO2)2].5H2O (3) and (NH4)2[Mo2O2S2(C10H12N2O8)].3.5H2O (4), molybdenum (V) atom adopts a distorted octahedral arrangement through a terminal oxygen atom, two bridging sulfur atoms and three atoms from the ligand (hydroxyl, alpha-, beta-carboxylates, sulfide or amine). The coordination mode of homocitrate ligand in K5(NH4)[Mo2O2S2(C7H5O7)2].3H2O.CH3OH (1) has been proposed in a tridentate fashion via its hydroxyl and a pair of carboxylate groups (alpha-, beta-carboxylates). The electrochemical properties of these complexes have been discussed.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA